These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23039957)

  • 21. [Blood cell component transfusion].
    Amagi K
    Rinsho Ketsueki; 1983 May; 24(5):491-7. PubMed ID: 6350642
    [No Abstract]   [Full Text] [Related]  

  • 22. The blood components--advancement in haemotherapy.
    Nathan IV; Han P
    J Singapore Paediatr Soc; 1986; 28(3-4):216-26. PubMed ID: 3599928
    [No Abstract]   [Full Text] [Related]  

  • 23. The transfusion tether: Bridging the gap between end-stage hematologic malignancies and optimal end-of-life care.
    Mannis GN; McNey LM; Gupta NK; Gross DM
    Am J Hematol; 2016 Jun; 91(4):364-5. PubMed ID: 26799788
    [No Abstract]   [Full Text] [Related]  

  • 24. [The use of erythrocyte concentrates, preserved at low temperature, in hematologic patients].
    Schleusner A; Raderecht C
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):813-8. PubMed ID: 6176505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why has demand for platelet components increased? A review.
    Estcourt LJ
    Transfus Med; 2014 Oct; 24(5):260-8. PubMed ID: 25327286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thrombocytopenia: is therapeutic platelet transfusion effective? Prophylactic platelet transfusion remains justified].
    Bethge W
    Dtsch Med Wochenschr; 2012 Dec; 137(50):2630. PubMed ID: 23225185
    [No Abstract]   [Full Text] [Related]  

  • 27. [Progress in treatment with blood and blood preparations with regard to achievements in blood preservation].
    Nowicki P
    Acta Haematol Pol; 1984; 15(3-4):213-21. PubMed ID: 6399433
    [No Abstract]   [Full Text] [Related]  

  • 28. [A guide on the use of blood and blood components. A group for the study of immunohematology and hemotherapy].
    Med Clin (Barc); 1988 Dec; 91(19):747-9. PubMed ID: 3236921
    [No Abstract]   [Full Text] [Related]  

  • 29. Shifting ground and gaps in transfusion support of patients with hematological malignancies.
    Cserti-Gazdewich C
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):553-560. PubMed ID: 30504357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of patients with hematologic malignancies and aplastic anemia who are refractory to platelet transfusions.
    Sandler SG
    Haematologia (Budap); 1998; 29(1):1-11. PubMed ID: 9704252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
    Vannucchi AM; Bosi A; Linari S; Guidi S; Longo G; Lombardini L; Mariani MP; Saccardi R; Laszlo D; Rossi Ferrini P
    Haematologica; 1997; 82(1):53-6. PubMed ID: 9107083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Transfusion of blood and blood derivatives. Immunological bases and indications].
    Janot C
    Rev Prat; 1994 Dec; 44(19):2639-45. PubMed ID: 7855535
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative studies for optimizing the collection of blood components in a multiple bag system].
    Taborski U; Müller N
    Beitr Infusionsther; 1988; 21():87-90. PubMed ID: 2463021
    [No Abstract]   [Full Text] [Related]  

  • 34. [Blood transfusion and blood-derived products transfusion. Immunologic principles and indications].
    Lamy B; Morel P; Hervé P
    Rev Prat; 1998 Mar; 48(5):549-53. PubMed ID: 9781121
    [No Abstract]   [Full Text] [Related]  

  • 35. Selective transfusion of blood components.
    McCredie KB
    Int Adv Surg Oncol; 1981; 4():145-71. PubMed ID: 7019094
    [No Abstract]   [Full Text] [Related]  

  • 36. Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies.
    De Fabritiis P; Dentamaro T; Picardi A; Cudillo L; Masi M; Amadori S
    Haematologica; 2004 Feb; 89(2):243-5. PubMed ID: 15003905
    [No Abstract]   [Full Text] [Related]  

  • 37. [Meaningful use of blood components in malignant diseases].
    Bucher U; Miloni E
    Schweiz Rundsch Med Prax; 1983 Nov; 72(45):1419-22. PubMed ID: 6657606
    [No Abstract]   [Full Text] [Related]  

  • 38. Transfusion support for leukaemia and oncology patients.
    Mayer K
    Clin Haematol; 1984 Feb; 13(1):93-8. PubMed ID: 6373084
    [No Abstract]   [Full Text] [Related]  

  • 39. Modern principles of blood transfusion therapy.
    Wallas CH; Panlilio AL; Jenkins DE
    J Tenn Med Assoc; 1978 Sep; 71(9):651-8. PubMed ID: 703308
    [No Abstract]   [Full Text] [Related]  

  • 40. The appropriate use of diagnostic services: (XV). A guide to blood transfusion practice.
    Smith DS
    Health Bull (Edinb); 1988 Jan; 46(1):8-17. PubMed ID: 3350658
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.